title: Withania somnifera extract attenuates stem cell factor-stimulated pigmentation in human epidermal equivalents through interruption of ERK phosphorylation within melanocytes.
abstract: We previously demonstrated that mitogen-activated protein kinase (MAPK) signaling, including microphthalmia-associated transcription factor (MITF) and cAMP response element-binding protein (CREB) phosphorylation, is a major pathway involved in up-regulating melanogenesis within human melanocytes in several hyperpigmentary disorders such as UVB melanosis and lentigo senilis. Recently, a redox imbalance was shown to be closely linked to a variety of altered cellular responses in which the precise balance between levels of oxidizing and reducing equivalents that reflect the intracellular redox condition profoundly affects intracellular signaling pathways, especially the MAPK pathway. To elucidate the effects of redox balance regulation on epidermal pigmentation, we used an antioxidant-rich extract of the herb Withania somnifera to assess its effect on stem cell factor (SCF)-stimulated pigmentation in human epidermal equivalents and analyzed its biological mechanism of action. Addition of the W. somnifera extract (WSE) caused a marked reduction in SCF-stimulated pigmentation in a dose-dependent manner after 14 days of treatment, which was accompanied by a significant decrease in eumelanin content. In WSE-treated human epidermal equivalents, melanocyte-specific proteins (including tyrosinase) were significantly suppressed at the gene and protein levels by WSE. Signaling analysis with immunoblots revealed that in human melanocytes or human melanoma cells treated with WSE, there was a marked deficiency in SCF-stimulated phosphorylation of ERK, MITF and CREB, but not of Raf-1 and MEK. Since WSE had no direct inhibitory effect on tyrosinase activity and no melano-cytotoxic effect on melanocytes present in the human epidermal equivalents or on cultured human melanocytes, the sum of these findings indicates that WSE attenuates SCF-stimulated pigmentation by preferentially interrupting ERK phosphorylation within melanocytes and can serve as a therapeutic tool for SCF-associated hyperpigmentary disorders.
authors.affiliation: School of Bioscience and Biotechnology, Tokyo University of Technology, 1404-1 Katakura, Hachioji, Tokyo 192-0982, Japan.
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Nakajima
authors.forename: Katsunori
authors.initials: K
authors.lastname: Fukazawa
authors.forename: Yuki
authors.initials: Y
authors.lastname: Wakabayashi
authors.forename: Kazumasa
authors.initials: K
authors.lastname: Wakamatsu
authors.forename: Genji
authors.initials: G
authors.lastname: Imokawa
mesh_terms: D015153:Blotting, Western; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D008544:Melanocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D010766:Phosphorylation / Q000187:drug effects; D010858:Pigmentation / Q000187:drug effects; D010936:Plant Extracts / Q000494:pharmacology*; D060888:Real-Time Polymerase Chain Reaction; D019089:Stem Cell Factor / Q000494:pharmacology*; D032341:Withania / Q000737:chemistry*
chemical_list: D010936:Plant Extracts; D019089:Stem Cell Factor; D048049:Extracellular Signal-Regulated MAP Kinases
references.citation: Mol Cancer Ther. 2006 Jun;5(6):1434-45
references.pmid: 16818501
references.citation: Anal Biochem. 1985 Feb 1;144(2):527-36
references.pmid: 3993914
references.citation: Cell. 2004 Nov 12;119(4):529-42
references.pmid: 15537542
references.citation: Arch Dermatol Res. 2011 May;303(4):263-76
references.pmid: 21442473
references.citation: Evid Based Complement Alternat Med. 2010 Jun;7(2):177-87
references.pmid: 18955307
references.citation: Cell. 2005 Mar 11;120(5):649-61
references.pmid: 15766528
references.citation: Cell. 1978 Nov;15(3):801-11
references.pmid: 83196
references.citation: Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1789-93
references.pmid: 7878059
references.citation: Biochim Biophys Acta. 2008 Nov;1780(11):1325-36
references.pmid: 18206122
references.citation: Biochem Biophys Res Commun. 1998 Jun 29;247(3):710-5
references.pmid: 9647758
references.citation: J Ethnopharmacol. 1999 Oct;67(1):27-35
references.pmid: 10616957
references.citation: Hum Exp Toxicol. 2005 Mar;24(3):137-47
references.pmid: 15901053
references.citation: J Biol Chem. 1993 Oct 15;268(29):21463-5
references.pmid: 7691810
references.citation: Phytomedicine. 2005 Mar;12(3):229-35
references.pmid: 15830846
references.citation: Am J Hum Genet. 2009 May;84(5):672-7
references.pmid: 19375057
references.citation: Biochem J. 1996 Feb 15;314 ( Pt 1):305-12
references.pmid: 8660299
references.citation: J Biol Chem. 1992 Dec 5;267(34):24675-80
references.pmid: 1280264
references.citation: J Biol Chem. 2007 Feb 16;282(7):4253-4264
references.pmid: 17150968
references.citation: J Biol Chem. 2004 Mar 12;279(11):10442-9
references.pmid: 14688258
references.citation: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references.pmid: 6606682
references.citation: Phytother Res. 2011 Sep;25(9):1398-411
references.pmid: 21678520
references.citation: Endocrinology. 1996 May;137(5):1627-33
references.pmid: 8612494
references.citation: Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1857-63
references.pmid: 17561491
references.citation: J Biol Chem. 2000 Oct 27;275(43):33321-8
references.pmid: 10921922
references.citation: Mol Cell Biol. 1994 Dec;14(12):7996-8006
references.pmid: 7969139
references.citation: Cell. 1975 Nov;6(3):331-43
references.pmid: 1052771
references.citation: Eur J Biochem. 1991 Jun 1;198(2):317-26
references.pmid: 1674912
references.citation: Pigment Cell Res. 1997 Aug;10(4):218-28
references.pmid: 9263329
references.citation: Phytother Res. 2007 Oct;21(10):905-13
references.pmid: 17562568
references.citation: Oncogene. 1999 Sep 30;18(40):5546-53
references.pmid: 10523831
references.citation: EMBO J. 1991 Dec;10(13):4121-8
references.pmid: 1721869
references.citation: J Invest Dermatol. 2004 May;122(5):1256-65
references.pmid: 15140230
references.citation: FASEB J. 2008 Apr;22(4):1155-68
references.pmid: 18039926
references.citation: J Invest Dermatol. 2001 Apr;116(4):571-7
references.pmid: 11286625
references.citation: Am J Pathol. 2003 Jul;163(1):333-43
references.pmid: 12819038
references.citation: Arch Dermatol Res. 2010 May;302(4):283-94
references.pmid: 19937254
references.citation: J Biol Chem. 1991 Sep 25;266(27):18352-7
references.pmid: 1917960
references.citation: J Invest Dermatol. 2001 Apr;116(4):578-86
references.pmid: 11286626
references.citation: Biochem Biophys Res Commun. 1999 Mar 24;256(3):657-63
references.pmid: 10080955
references.citation: Mol Cell Biol. 1994 Oct;14(10):6926-35
references.pmid: 7523859
references.citation: J Invest Dermatol. 1995 Jul;105(1):32-7
references.pmid: 7615973
references.citation: Vascul Pharmacol. 2006 Jun;44(6):406-10
references.pmid: 16713367
references.citation: Am J Pathol. 2004 Dec;165(6):2099-109
references.pmid: 15579452
references.citation: Mol Cell Biochem. 2004 May;260(1-2):39-47
references.pmid: 15228084